Ticker League

Cash on Hand for IDEXX Laboratories (IDXX) 1991-2026

As of · Reported

Metric

Latest period

$201M

YoY change

-37.5%

5Y CAGR

-14.1%

Peak year (FY2017)

$472M

Cash on Hand history chart for IDEXX Laboratories (IDXX) from 2016 to 2025

Latest: $180M

Cash on Hand growth chart for IDEXX Laboratories (IDXX) from 2016 to 2025

Latest: -37.5%

Cash on Hand history table for IDEXX Laboratories (IDXX) from 1991 to 2025

  • FY2025$180M-37.5%
  • FY2024$288M-36.5%
  • FY2023$454M+303.3%
  • FY2022$113M-22.1%
  • FY2021$144M-62.4%
  • FY2020$384M+325.0%
  • FY2019$90.3M-27.0%
  • FY2018$124M-73.8%
  • FY2017$472M+20.4%
  • FY2016$392M+14.4%
  • FY2015$343M+6.2%
  • FY2014$323M+15.6%
  • FY2013$279M+24.6%
  • FY2012$224M+21.8%
  • FY2011$184M+17.2%
  • FY2010$157M+47.0%
  • FY2009$107M+35.3%
  • FY2008$78.9M+30.7%
  • FY2007$60.4M-37.6%
  • FY2006$96.7M-27.2%
  • FY2005$133M-3.3%
  • FY2004$137M-37.8%
  • FY2003$221M+49.9%
  • FY2002$147M+85.0%
  • FY2001$79.6M+5.8%
  • FY2000$75.2M+28.3%
  • FY1999$58.6M-46.3%
  • FY1998$109M+2.0%
  • FY1997$107M-16.2%
  • FY1996$128M-14.5%
  • FY1995$149M+492.5%
  • FY1994$25.2M+33.3%
  • FY1993$18.9M+9.9%
  • FY1992$17.2M+84.9%
  • FY1991$9.3M—

Cash on Hand values are taken from IDEXX Laboratories's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at IDEXX Laboratories (IDXX)

According to IDEXX Laboratories's latest reported financial statements, the company's latest reported cash and short-term investments is $201M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

2025's annual cash and short-term investments for IDEXX Laboratories (IDXX) came in at $180M – plunged 37.5% year-over-year.

Looking at the 2020–2025 (5 years) stretch, IDEXX Laboratories cash and short-term investments compounded at -14.1% per year, with a net decline across the window.

IDEXX Laboratories cash and short-term investments plunged from $472M in 2017 to $180M in 2025, a 61.8% drawdown.

$472M stands as the all-time-high annual cash and short-term investments, posted in 2017, against a low of $9.3M during 1991.

IDEXX Laboratories Cash on Hand by Year

IDEXX Laboratories Cash on Hand 2025: $180M

2025's cash and short-term investments for IDEXX Laboratories came in at $180M, plunged 37.5% below 2024.

IDEXX Laboratories Cash on Hand 2024: $288M

IDEXX Laboratories posted cash and short-term investments of $288M in 2024, plunged 36.5% below 2023.

IDEXX Laboratories Cash on Hand 2023: $454M

In 2023, IDEXX Laboratories reported cash and short-term investments of $454M, surged 303.3% from 2022.

IDEXX Laboratories Cash on Hand 2022: $113M

IDEXX Laboratories cash and short-term investments in 2022 was $113M, declined 22.1% below 2021.

IDEXX Laboratories Cash on Hand 2021: $144M

IDEXX Laboratories cash and short-term investments in 2021 was $144M.

See more financial history for IDEXX Laboratories (IDXX).

Sector peers by Cash on Hand

Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest cash and short-term investments

Frequently asked questions

Trains Cash & Reserves

IDEXX Laboratories (IDXX) Key Financials

Charts, filings, and peer comparison for every metric

Operations

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.